Mancebo, MC, Greenberg, B, Grant, JE, Pinto, A, Eisen, JL, Dyck, I, et al. Correlates of occupational disability in a clinical sample of obsessive–compulsive disorder. Compr Psychiatry
2008; 49: 43–50.
Eisen, JL, Mancebo, MA, Pinto, A, Coles, ME, Pagano, ME, Stout, R, et al. Impact of obsessive–compulsive disorder on quality of life. Compr Psychiatry
2006; 47: 270–5.
Ayuso-Mateos, J. Global Burden of Obsessive–compulsive Disorder in the Year 2000.
World Health Organization, 2006.
Ruscio, AM, Stein, DJ, Chiu, WT, Kessler, RC. The epidemiology of obsessive–compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry
2010; 15: 53–63.
Williams, MT, Farris, SG, Turkheimer, E, Pinto, A, Ozanick, K, Franklin, ME, et al. Myth of the pure obsessional type in obsessive–compulsive disorder. Depress Anxiety
2011; 28: 495–500.
Abramowitz, JS, Taylor, S, McKay, D. Obsessive–compulsive disorder. Lancet
2009; 374: 491–9.
Stein, DJ. Obsessive–compulsive disorder. Lancet
2002; 360: 397–405.
Rachman, S. A cognitive theory of obsessions: elaborations. Behav Res Ther
1998; 36: 385–401.
Rachman, S. A cognitive theory of obsessions. Behav Res Ther
1997; 35: 793–802.
Maia, TV, Cooney, RE, Peterson, BS. The neural bases of obsessive–compulsive disorder in children and adults. Dev Psychopathol
2008; 20: 1251–83.
Welter, ML, Burbaud, P, Fernandez-Vidal, S, Bardinet, E, Coste, J, Piallat, B, et al. Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacy. Transl Psychiatry
2011; 1: e5.
Modell, JG, Mountz, JM, Curtis, GC, Greden, JF. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive–compulsive disorder. J Neuropsychiatry Clin Neurosci
1989; 1: 27–36.
Baxter, LR, Schwartz, JM, Bergman, KS, Szuba, MP, Guze, BH, Mazziotta, JC, et al. Caudate glucose metabolic rate changes with both drug and behaviour therapy for obsessive–compulsive disorder. Arch Gen Psychiatry
1992; 49: 681–9.
Radua, J, van den Heuvel, OA, Surguladze, S, Mataix-Cols, D. Meta-analytical comparison of voxel-based morphometry studies in obsessive–compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry
2010; 67: 701–11.
Chamberlain, SR, Menzies, L, Hampshire, A, Suckling, J, Fineberg, NA, del Campo, N, et al. Orbitofrontal dysfunction in patients with obsessive–compulsive disorder and their unaffected relatives. Science
2008; 321: 421–2.
Harrison, BJ, Soriano-Mas, C, Pujol, J, Ortiz, H, Lopez-Sola, M, Hernandez-Ribas, R, et al. Altered corticostriatal functional connectivity in obsessive–compulsive disorder. Arch Gen Psychiatry
2009; 66: 1189–200.
Pittenger, C, Bloch, MH, Williams, K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther
2011; 132: 314–32.
Chakrabarty, K, Bhattacharyya, S, Christopher, R, Khanna, S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology
2005; 30: 1735–40.
Rosenberg, DR, Benazon, NR, Gilbert, A, Sullivan, A, Moore, GJ. Thalamic volume in pediatric obsessive–compulsive disorder patients before and after cognitive behavioural therapy. Biol Psychiatry
2000; 48: 294–300.
Hansen, ES, Hasselbalch, S, Law, I, Bolwig, TG. The caudate nucleus in obsessive–compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol
2002; 5: 1–10.
Stewart, SE, Mayerfeld, C, Arnold, PD, Crane, AJ, O'Dushlaine, C, Fagerness, JA, et al. Meta-analysis of association between obsessive–compulsive disorder and the 3’ region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet
2013; 162B: 367–79.
Stewart, SE, Yu, D, Scharf, JM, Neale, BM, Fagerness, JA, Mathews, CA, et al. Genome-wide association study of obsessive–compulsive disorder. Mol Psychiatry
2013; 18: 788–98.
Wu, K, Hanna, GL, Rosenberg, DR, Arnold, PD. The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder. Pharmacol Biochem Behav
2012; 100: 726–35.
Rotge, JY, Aouizerate, B, Tignol, J, Bioulac, B, Burbaud, P, Guehl, D. The glutamate-based genetic immune hypothesis in obsessive–compulsive disorder. An integrative approach from genes to symptoms. Neuroscience
2010; 165: 408–17.
Najjar, S, Pearlman, DM, Alper, K, Najjar, A, Devinsky, O. Neuroinflammation and psychiatric illness. J Neuroinflammation
2013; 10: 43.
Frick, LR, Williams, K, Pittenger, C. Microglial dysregulation in psychiatric disease. Clin Dev Immunol
2013; 2013: 608–54.
Brimberg, L, Benhar, I, Mascaro-Blanco, A, Alvarez, K, Lotan, D, Winter, C, et al. Behavioural, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology
2013; 37: 2076–87.
Kirvan, CA, Cox, CJ, Swedo, SE, Cunningham, MW. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol
2007; 178: 7412–21.
Kirvan, CA, Swedo, SE, Heuser, JS, Cunningham, MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med
2003; 9: 914–20.
Kirvan, CA, Swedo, SE, Snider, LA, Cunningham, MW. Antibody-mediated neuronal cell signaling in behaviour and movement disorders. J Neuroimmunol
2006; 179: 173–9.
Cunningham, MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol
2012; 24: 408–16.
Swedo, SE, Leonard, HL, Rapoport, JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics
2004; 113: 907–11.
Swedo, SE, Leonard, HL, Garvey, M, Mittleman, B, Allen, AJ, Perlmutter, , et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry
1998; 155: 264–71.
Singer, HS, Giuliano, JD, Hansen, BH, Hallett, JJ, Laurino, JP, Benson, M, et al. Antibodies against human putamen in children with Tourette syndrome. Neurology
1998; 50: 1618–24.
Kansy, JW, Katsovich, L, McIver, KS, Pick, J, Zabriskie, JB, Lombroso, PJ, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol
2006; 181: 165–76.
Fibbe, LA, Cath, DC, van den Heuvel, OA, Veltman, DJ, Tijssen, MA, van Balkom, AJ. Relationship between movement disorders and obsessive–compulsive disorder: beyond the obsessive–compulsive-tic phenotype. A systematic review. J Neurol Neurosurg Psychiatry
2012; 83: 646–54.
Hounie, AG, Pauls, DL, Mercadante, MT, Rosario-Campos, MC, Shavitt, RD, de Mathis, MA, et al. Obsessive–compulsive spectrum disorders in rheumatic fever with and without Sydenham's chorea. J Clin Psychiatry
2004; 65: 994–9.
Maia, DP, Teixeira, AL Jr, Quintao Cunningham, MC, Cardoso, F. Obsessive compulsive behaviour, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology
2005; 64: 1799–801.
Mercadante, MT, Diniz, JB, Hounie, AG, Ferrao, Y, Alvarenga, P, Brotto, S, et al. Obsessive–compulsive spectrum disorders in rheumatic fever patients. J Neuropsychiatry Clin Neurosci
2005; 17: 544–7.
Asbahr, FR, Garvey, MA, Snider, LA, Zanetta, DM, Elkis, H, Swedo, SE. Obsessive–compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry
2005; 57: 1073–6.
Swedo, SE, Leonard, HL, Casey, BJ, Mannheim, GB, Lenane, MC, Rettew, DC, et al. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics
1993; 91: 706–13.
Martino, D, Church, A, Giovannoni, G. Are antibasal ganglia antibodies important, and clinically useful?
2007; 7: 32–41.
Kirvan, CA, Swedo, SE, Kurahara, D, Cunningham, MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity
2006; 39: 21–9.
Dale, RC, Brilot, F. Autoimmune basal ganglia disorders. J Child Neurol
2012; 27: 1470–81.
Dale, RC, Church, AJ, Surtees, RA, Lees, AJ, Adock, JE, Harding, B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain
2004; 127: 21–33.
Sanchez-Carpintero, R, Albesa, SA, Crespo, N, Villoslada, P, Narbona, J. A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. J Neurol
2009; 256: 1103–8.
Yaddanapudi, K, Hornig, M, Serge, R, De Miranda, J, Baghban, A, Villar, G, et al. Passive transfer of streptococcus-induced antibodies reproduces behavioural disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry
2010; 15: 712–26.
Dale, RC, Merheb, V, Pillai, S, Wang, D, Cantrill, L, Murphy, TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain
2012; 135: 3453–68.
Dale, RC, Candler, PM, Church, AJ, Wait, R, Pocock, JM, Giovannoni, G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol
2006; 172: 187–97.
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med
2009; 151: 264–9, .
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Wilkinson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000; 283: 2008–12.
Wells, G, Shea, B, O'Connell, D, Peterson, J, Welch, V, Losos, M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
Fritschy, JM. Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci
2008; 28: 2365–70.
Church, AJ, Dale, RC, Giovannoni, G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?
Arch Dis Child
2004; 89: 611–4.
DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials
1986; 7: 177–88.
Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ
2003; 327: 557–60.
Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–34.
Harbord, RM, Higgins, JPT. Meta-regression in Stata. Stata J
2008; 8: 493–519.
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, et al. The Yale–Brown Obsessive–Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry
1989; 46: 1006–11.
Kawikova, I, Grady, BPX, Tobiasova, Z, Zhang, Y, Vojdani, A, Katsovich, L, et al. Children with Tourette's syndrome may suffer immunoglobulin A dysgammaglobulinemia: preliminary report. Biol Psychiatry
2010; 67: 679–83.
Singer, H, Gause, C, Grados, M. Antineuronal antibodies in obsessive–compulsive disorder: Comparisons in children with OCD-only, OCD + chronic TICS and OCD + PANDAS. Eur Psychiatry
2009; 24: S175.
Zuccolo, A, Mascaro-Blanco, A, Alvarez, K, Stoner, J, Cunningham, M. Antineuronal antibodies in a heterogeneous ‘PANDAS’ group with tics and obsessive compulsive disorder. Dev Med Child Neurol
2012; 54: 141.
Murphy, T, Storch, E. The relationship between streptococcal antibodies and the course of OCD and tics in a pediatric population. Eur Psychiatry
2009; 24: S177.
Swedo, SE, Kilpatrick, K, Shapiro, MB, Mannheim, G, Leonard, H. Antineuronal antibodies (AnA) in Sydenham's Chorea (SC) and obsessive–compulsive disorder (OCD) [abstract]. Pediatr Res
1991; 29: 364A.
Nicholson, TRJ, Ferdinando, S, Krishnaiah, RB, Anhoury, S, Lennox, BR, Mataix-Cols, D, et al. Prevalence of anti-basal ganglia antibodies in adult obsessive–compulsive disorder: cross-sectional study. Br J Psychiatry
2012; 200: 381–6.
Gause, C, Morris, C, Vernekar, S, Pardo-Villamizar, C, Grados, MA, Singer, HS. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol
2009; 214: 118–24.
Maina, G, Albert, U, Bogetto, F, Borghese, C, Cat Berro, A, Mutani, R, et al. Anti-brain antibodies in adult patients with obsessive–compulsive disorder. J Affect Disord
2009; 116: 192–200.
Bhattacharyya, S, Khanna, S, Chakrabarty, K, Mahadevan, A, Christopher, R, Shankar, SK. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive–compulsive disorder. Neuropsychopharmacology
2009; 34: 2489–96.
Morer, A, Lazaro, L, Sabater, L, Massana, J, Castro, J, Graus, F. Antineuronal antibodies in a group of children with obsessive–compulsive disorder and Tourette syndrome. J Psychiatr Res
2008; 42: 64–8.
Dale, RC, Heyman, I, Giovannoni, G, Church, AWJ. Incidence of anti-brain antibodies in children with obsessive–compulsive disorder. Br J Psychiatry
2005; 187: 314–9.
Rose, NR, Bona, C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today
1993; 14: 426–30.
Witebsky, E, Rose, NR, Terplan, K, Paine, JR, Egan, RW. Chronic thyroiditis and autoimmunization. JAMA
1957; 164: 1439–47.
Fluitman, S, Denys, D, Vulink, N, Schutters, S, Heijnen, C, Westenberg, H. Lipopolysaccharide-induced cytokine production in obsessive–compulsive disorder and generalized social anxiety disorder. Psychiatry Res
2010; 178: 313–6.
Fluitman, SB, Denys, DA, Heijnen, CJ, Westenberg, HG. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive–compulsive disorder. Psychoneuroendocrinology
2010; 35: 906–11.
Poe, LB. Radiological cases of the month. Gastrointestinal manifestations of hemolytic uremic syndrome. Am J Dis Child
1989; 143: 1481–2.
Rippel, CA, Hong, JJ, Yoon, DY, Williams, PN, Singer, HS. Methodologic factors affect the measurement of anti-basal ganglia antibodies. Ann Clin Lab Sci
2005; 35: 121–30.
Morshed, SA, Parveen, S, Leckman, JF, Mercadante, MT, Bittencourt Kiss, MH, Miguel, EC, et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry
2001; 50: 566–77.
Dickerson, F, Stallings, C, Vaughan, C, Origoni, A, Khushalani, S, Yolken, R. Antibodies to the glutamate receptor in mania. Bipolar Disord
2012; 14: 547–53.
Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Meizan, L, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol
2008; 27: 1091–8.
Irani, SR, Bera, K, Waters, P, Zulliani, L, Maxwell, S, Zandi, MS, et al. N-methyl-Daspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain
2010; 133: 1655–67.